Compounds > tadalafil

Page last updated: 2024-09-02

tadalafil and Central Serous Retinopathy

tadalafil has been researched along with Central Serous Retinopathy in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	7 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonnet, S; Lepièce, G; Smal, C	1
Das, D; Lobo, A; Panigrahi, PK; Roy, R; Saurabh, K	1
French, DD; Margo, CE	1
Guigou, S; Nadeau, S; Nguyen, F	1
Gordon-Bennett, P; Rimmer, T	1
Aliferis, K; Farpour, B; Matter, MA; Petropoulos, IK; Safran, AB	1
Bozkurt, Y; Çaça, I; Murat, M; Şahin, A; Türkcü, FM; Yüksel, H	1

Reviews

1 review(s) available for tadalafil and Central Serous Retinopathy

Article	Year
Central serous chorioretinopathy following oral tadalafil. Eye (London, England), 2012, Volume: 26, Issue:1 Topics: Administration, Oral; Carbolines; Central Serous Chorioretinopathy; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Tadalafil; Visual Acuity	2012

Other Studies

6 other study(ies) available for tadalafil and Central Serous Retinopathy

Article	Year
[Central serous chorioretinopathy following the use of phosphodiesterase 5 inhibitors]. Revue medicale de Liege, 2017, Volume: 72, Issue:11 Topics: Central Serous Chorioretinopathy; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Tomography, Optical Coherence	2017
Central serous chorioretinopathy following oral tadalafil intake. Clinical & experimental optometry, 2014, Volume: 97, Issue:5 Topics: Administration, Oral; Carbolines; Central Serous Chorioretinopathy; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Retina; Tadalafil; Tomography, Optical Coherence	2014
Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study. Retina (Philadelphia, Pa.), 2010, Volume: 30, Issue:2 Topics: Adolescent; Adult; Carbolines; Case-Control Studies; Central Serous Chorioretinopathy; Databases, Factual; Drug Prescriptions; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Product Surveillance, Postmarketing; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United States; United States Department of Veterans Affairs; Vardenafil Dihydrochloride; Young Adult	2010
[Serous central chorioretinopathy and tadalafil: a case report]. Journal francais d'ophtalmologie, 2012, Volume: 35, Issue:2 Topics: Carbolines; Central Serous Chorioretinopathy; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Tadalafil; Vasodilator Agents	2012
Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors? Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2012, Volume: 227, Issue:2 Topics: Aged; Carbolines; Central Serous Chorioretinopathy; Erectile Dysfunction; Fluorescein Angiography; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Sulfones; Tadalafil; Tomography, Optical Coherence; Triazines; Vardenafil Dihydrochloride; Vision Disorders	2012
Central serous chorioretinopathy due to tadalafil use. International ophthalmology, 2013, Volume: 33, Issue:2 Topics: Adult; Carbolines; Central Serous Chorioretinopathy; Erectile Dysfunction; Humans; Male; Phosphodiesterase 5 Inhibitors; Tadalafil; Tomography, Optical Coherence	2013